×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Lymphoma Cancer
Katie Kosko
Productivity loss among parent caregivers associated with poor health-related quality of life in pediatric advanced stage Hodgkin lymphoma.
Ryan Hamner
In order to help others, this survivor and author must "bare all" to get his message out.
Jason M. Broderick and Katie Kosko
Treating younger patients with low-risk diffuse large B-cell lymphoma (DLBCL) with two fewer front-line cycles of standard treatment greatly reduced toxicity without sacrificing efficacy.
Jason M. Broderick
The Food and Drug Administration granted a priority review to Revlimid (lenalidomide) plus Rituxan (rituximab) for the treatment of patients with previously treated follicular lymphoma and marginal zone lymphoma.
Kristie L. Kahl
The Food and Drug Administration granted a priority review to polatuzumab vedotin in combination with bendamustine plus Rituxan (rituximab) for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Jessica Skarzynski
While some high-risk patients with mantle cell lymphoma may benefit from aggressive initial therapy, a recent study found that this may not be necessary for others who could benefit from more targeted therapies.
Shira Zwebner
Outwardly, you start to look like your old self again while inside you're still licking the wounds of your cancer battle.
Parameswaran Venugopal, M.D., reacts to the availability of newer novel-based therapies and the variety of treatment strategies that can be used to better manage patients with follicular lymphoma.
Gerald Koch and his oncologist, Parameswaran Venugopal, M.D., provide advice to help encourage newly diagnosed patients with follicular lymphoma to take a proactive role in managing their journey.
Insight related to the importance of coordinated care and the rationale for involving various health care professionals in the management of patients who are diagnosed with follicular lymphoma.